Demant A/S (DEMANT.CO)
Makes and sells hearing aids, plus runs clinics that test hearing and balance.
284.20+0.02%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+16.1%
The outlook
Demant trades near its 52-week high with a consensus Buy rating from analysts, though the average price target sits about 4% below current levels. The stock is trading above both its 50- and 200-day moving averages, reflecting an uptrend. At a trailing P/E of 25.4, it's priced at a premium relative to recent analyst valuations.
What’s behind the score
Analyst consensusBuy — 2.0 avg of 20 analysts
Price trendAbove its 50- & 200-day averages
52-week range98% of the way from its 52-week low to high
Price targetAvg target -4% vs current price
Analyst price target
~12-month · 20 analysts272.90average target-4.0% vs now
Now 284.20
Low 220.00High 325.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$59.94B
52-wk high
286.80
52-wk low
175.00
50-day avg
259.78
200-day avg
222.40
Trailing P/E
25.4